BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19800201)

  • 1. The dystrobrevin binding protein 1 (DTNBP1) gene is associated with schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample.
    Riley B; Kuo PH; Maher BS; Fanous AH; Sun J; Wormley B; O'Neill FA; Walsh D; Zhao Z; Kendler KS
    Schizophr Res; 2009 Dec; 115(2-3):245-53. PubMed ID: 19800201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study.
    Morris DW; McGhee KA; Schwaiger S; Scully P; Quinn J; Meagher D; Waddington JL; Gill M; Corvin AP
    Schizophr Res; 2003 Apr; 60(2-3):167-72. PubMed ID: 12591580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the dystrobrevin binding protein 1 gene (DTNBP1) in a bipolar case-control study (BACCS).
    Gaysina D; Cohen-Woods S; Chow PC; Martucci L; Schosser A; Ball HA; Tozzi F; Perry J; Muglia P; Craig IW; McGuffin P; Farmer A
    Am J Med Genet B Neuropsychiatr Genet; 2009 Sep; 150B(6):836-44. PubMed ID: 19089808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No association of dysbindin with symptom factors of schizophrenia in an Irish case-control sample.
    Bergen SE; Fanous AH; Kuo PH; Wormley BK; O'Neill FA; Walsh D; Riley BP; Kendler KS
    Am J Med Genet B Neuropsychiatr Genet; 2010 Mar; 153B(2):700-705. PubMed ID: 19760674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia.
    Fanous AH; van den Oord EJ; Riley BP; Aggen SH; Neale MC; O'Neill FA; Walsh D; Kendler KS
    Am J Psychiatry; 2005 Oct; 162(10):1824-32. PubMed ID: 16199828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysbindin gene (DTNBP1) and schizophrenia in Korean population.
    Pae CU; Mandelli L; De Ronchi D; Kim JJ; Jun TY; Patkar AA; Serretti A
    Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):137-42. PubMed ID: 19252939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association study of the dystrobrevin-binding gene with schizophrenia in Australian and Indian samples.
    Holliday EG; Handoko HY; James MR; McGrath JJ; Nertney DA; Tirupati S; Thara R; Levinson DF; Hayward NK; Mowry BJ; Nyholt DR
    Twin Res Hum Genet; 2006 Aug; 9(4):531-9. PubMed ID: 16899160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 5-haplotype of dysbindin gene (DTNBP1) polymorphisms for the susceptibility to bipolar I disorder.
    Pae CU; Serretti A; Mandelli L; Yu HS; Patkar AA; Lee CU; Lee SJ; Jun TY; Lee C; Paik IH; Kim JJ
    Am J Med Genet B Neuropsychiatr Genet; 2007 Jul; 144B(5):701-3. PubMed ID: 17192893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DTNBP1 (Dystrobrevin binding protein 1) and schizophrenia: association evidence in the 3' end of the gene.
    Duan J; Martinez M; Sanders AR; Hou C; Burrell GJ; Krasner AJ; Schwartz DB; Gejman PV
    Hum Hered; 2007; 64(2):97-106. PubMed ID: 17476109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of HapMap tag-SNPs in dysbindin (DTNBP1) reveals evidence of consistent association with schizophrenia.
    Voisey J; Swagell CD; Hughes IP; Lawford BR; Young RM; Morris CP
    Eur Psychiatry; 2010 Oct; 25(6):314-9. PubMed ID: 20615671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease.
    Van Den Bogaert A; Schumacher J; Schulze TG; Otte AC; Ohlraun S; Kovalenko S; Becker T; Freudenberg J; Jönsson EG; Mattila-Evenden M; Sedvall GC; Czerski PM; Kapelski P; Hauser J; Maier W; Rietschel M; Propping P; Nöthen MM; Cichon S
    Am J Hum Genet; 2003 Dec; 73(6):1438-43. PubMed ID: 14618545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of high-resolution HapMap of DTNBP1 (Dysbindin) suggests no consistency between reported common variant associations and schizophrenia.
    Mutsuddi M; Morris DW; Waggoner SG; Daly MJ; Scolnick EM; Sklar P
    Am J Hum Genet; 2006 Nov; 79(5):903-9. PubMed ID: 17033966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of tagging sequence variants in DTNBP1 shows no association with schizophrenia or with its composite neurocognitive endophenotypes.
    Peters K; Wiltshire S; Henders AK; Dragović M; Badcock JC; Chandler D; Howell S; Ellis C; Bouwer S; Montgomery GW; Palmer LJ; Kalaydjieva L; Jablensky A
    Am J Med Genet B Neuropsychiatr Genet; 2008 Oct; 147B(7):1159-66. PubMed ID: 18314870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families.
    van den Oord EJ; Sullivan PF; Jiang Y; Walsh D; O'Neill FA; Kendler KS; Riley BP
    Mol Psychiatry; 2003 May; 8(5):499-510. PubMed ID: 12808430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A reappraisal of the association between Dysbindin (DTNBP1) and schizophrenia in a large combined case-control and family-based sample of German ancestry.
    Strohmaier J; Frank J; Wendland JR; Schumacher J; Jamra RA; Treutlein J; Nieratschker V; Breuer R; Mattheisen M; Herms S; Mühleisen TW; Maier W; Nöthen MM; Cichon S; Rietschel M; Schulze TG
    Schizophr Res; 2010 May; 118(1-3):98-105. PubMed ID: 20083391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1).
    Williams NM; Preece A; Morris DW; Spurlock G; Bray NJ; Stephens M; Norton N; Williams H; Clement M; Dwyer S; Curran C; Wilkinson J; Moskvina V; Waddington JL; Gill M; Corvin AP; Zammit S; Kirov G; Owen MJ; O'Donovan MC
    Arch Gen Psychiatry; 2004 Apr; 61(4):336-44. PubMed ID: 15066891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families.
    Thiselton DL; Vladimirov VI; Kuo PH; McClay J; Wormley B; Fanous A; O'Neill FA; Walsh D; Van den Oord EJ; Kendler KS; Riley BP
    Biol Psychiatry; 2008 Mar; 63(5):449-57. PubMed ID: 17825267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysbindin gene variability is associated with cognitive abnormalities in first-episode non-affective psychosis.
    Varela-Gomez N; Mata I; Perez-Iglesias R; Rodriguez-Sanchez JM; Ayesa R; Fatjo-Vilas M; Crespo-Facorro B
    Cogn Neuropsychiatry; 2015; 20(2):144-56. PubMed ID: 25530342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association study of the dysbindin (DTNBP1) gene in schizophrenia from the Japanese population.
    Tochigi M; Zhang X; Ohashi J; Hibino H; Otowa T; Rogers M; Kato T; Okazaki Y; Kato N; Tokunaga K; Sasaki T
    Neurosci Res; 2006 Oct; 56(2):154-8. PubMed ID: 16876895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the DTNBP1 locus with schizophrenia in a U.S. population.
    Funke B; Finn CT; Plocik AM; Lake S; DeRosse P; Kane JM; Kucherlapati R; Malhotra AK
    Am J Hum Genet; 2004 Nov; 75(5):891-8. PubMed ID: 15362017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.